The development and therapeutic potential of protein kinase inhibitors

Philip Cohen

doi:10.1016/S1367-5931(99)80067-2

The development and therapeutic potential of protein kinase inhibitors

Philip Cohen

Research output: Contribution to journal › Review article › peer-review

181 Citations (Scopus)

Abstract

A number of small cell-permeant protein kinase inhibitors have been developed that have the potential for treating a variety of diseases. The basis for the specificity of several of these drugs has been elucidated and a number are undergoing human clinical trials.

Original language	English
Pages (from-to)	459-465
Number of pages	7
Journal	Current Opinion in Chemical Biology
Volume	3
Issue number	4
DOIs	https://doi.org/10.1016/S1367-5931(99)80067-2
Publication status	Published - Aug 1999

ASJC Scopus subject areas

Analytical Chemistry
Biochemistry

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S1367-5931(99)80067-2Licence: Elsevier User Licence

Cite this

@article{ec7bf94b6ea44d9e891fe9bc33edf5ef,

title = "The development and therapeutic potential of protein kinase inhibitors",

abstract = "A number of small cell-permeant protein kinase inhibitors have been developed that have the potential for treating a variety of diseases. The basis for the specificity of several of these drugs has been elucidated and a number are undergoing human clinical trials.",

author = "Philip Cohen",

year = "1999",

month = aug,

doi = "10.1016/S1367-5931(99)80067-2",

language = "English",

volume = "3",

pages = "459--465",

journal = "Current Opinion in Chemical Biology",

issn = "1367-5931",

publisher = "Elsevier",

number = "4",

}

TY - JOUR

T1 - The development and therapeutic potential of protein kinase inhibitors

AU - Cohen, Philip

PY - 1999/8

Y1 - 1999/8

N2 - A number of small cell-permeant protein kinase inhibitors have been developed that have the potential for treating a variety of diseases. The basis for the specificity of several of these drugs has been elucidated and a number are undergoing human clinical trials.

AB - A number of small cell-permeant protein kinase inhibitors have been developed that have the potential for treating a variety of diseases. The basis for the specificity of several of these drugs has been elucidated and a number are undergoing human clinical trials.

UR - http://www.scopus.com/inward/record.url?scp=0033178359&partnerID=8YFLogxK

U2 - 10.1016/S1367-5931(99)80067-2

DO - 10.1016/S1367-5931(99)80067-2

M3 - Review article

C2 - 10419844

AN - SCOPUS:0033178359

SN - 1367-5931

VL - 3

SP - 459

EP - 465

JO - Current Opinion in Chemical Biology

JF - Current Opinion in Chemical Biology

IS - 4

ER -

The development and therapeutic potential of protein kinase inhibitors

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this